Washington § 69.78.040 Requirements for state entities or hospitals conducting clinical trials.

Washington Statutes

§ 69.78.040 — Requirements for state entities or hospitals conducting clinical trials.

Washington § 69.78.040

Title 69FOOD, DRUGS, COSMETICS, AND POISONS

Ch. 69.78DIVERSITY IN CLINICAL TRIALS

This text of Washington § 69.78.040 (Requirements for state entities or hospitals conducting clinical trials.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Wash. Rev. Code § 69.78.040 (2026).

Text

Any state entity or hospital that receives funding from the national institutes of health to conduct clinical trials of drugs or medical devices shall:

(1)Adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic groups to participate in clinical trials. This policy must include requirements that investigators who are conducting clinical trials collaborate with community-based organizations and use methods recognized by the United States food and drug administration to identify and recruit such persons to participate in those clinical trials;

(2)Provide information to trial participants in languages other than English;

(3)Provide translation services or bilingual staff for trial screening;

(4)Provide culturally specific

Free access — add to your briefcase to read the full text and ask questions with AI

Any state entity or hospital that receives funding from the national institutes of health to conduct clinical trials of drugs or medical devices shall:

(1) Adopt a policy concerning the identification and recruitment of persons who are members of underrepresented demographic groups to participate in clinical trials. This policy must include requirements that investigators who are conducting clinical trials collaborate with community-based organizations and use methods recognized by the United States food and drug administration to identify and recruit such persons to participate in those clinical trials;

(2) Provide information to trial participants in languages other than English;

(3) Provide translation services or bilingual staff for trial screening;

(4) Provide culturally specific recruitment materials alongside general enrollment materials; and

(5) Provide electronic consent when not prohibited by the granting entity or federal regulations.